NEW YORK (GenomeWeb News) – Roche announced today that its Roche NimbleGen business will collaborate with High Throughput Genomics on gene expression applications.

Under the pact, Roche NimbleGen will provide HTG with high-density, multiplex DNA microarray slides. HTG will apply its quantitative nuclease protection assay process to the arrays to enable researchers to rapidly measure gene expression levels in a variety of sample types.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.